Cleared Traditional

K243910 - Retraxil

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2025
Decision
279d
Days
-
Risk

K243910 is an FDA 510(k) clearance for the Retraxil. Classified as Cord, Retraction (product code MVL).

Submitted by Kulzer, LLC (South Bend, US). The FDA issued a Cleared decision on September 24, 2025 after a review of 279 days - an extended review cycle.

This device falls under the Dental FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Kulzer, LLC devices

FDA 510(k) Submission Details - K243910

510(k) Number K243910 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2024
Decision Date September 24, 2025
Days to Decision 279 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
152d slower than avg
Panel avg: 127d · This submission: 279d
Pathway characteristics
Predicate-based equivalence.

MVL Device Classification - Class 0,

Product Code MVL Cord, Retraction
Device Class -

Regulatory Peers - MVL Cord, Retraction

All 33
Devices cleared under the same product code (MVL) and FDA review panel - the closest regulatory comparables to K243910.
CyClean Cord
K254239 · SS GLOBAL · Mar 2026
One-Stop
K253797 · Mediclus Co., Ltd. · Feb 2026
Stasis Gel
K211420 · Belport Company, Inc., Gingi-Pak · Mar 2022
Gingi-Aid Gel
K211419 · Belport Company, Inc., Gingi-Pak · Jan 2022
VOCO Retraction Paste
K213149 · Voco GmbH · Dec 2021
STATSTIX
K200764 · Centrix Incorporated · Oct 2020